High Serum Vascular Endothelial Growth Factor (VEGF) Level Is An Adverse Prognostic Factor In High Risk Diffuse Large B Cell Lymphoma (DLBCL) Patients Treated with Dose Dense Chemoimmunotherapy and Systemic CNS Prophylaxis Results From a Nordic Phase II Study

Research output: Contribution to journalPublished meeting abstract

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Hematology
Original languageEnglish
Pages (from-to)1686-1686
JournalBlood
Volume116
Issue number21
Publication statusPublished - 2010
Publication categoryResearch
Peer-reviewedYes
Event52nd Annual Meeting of the American-Society-of-Hematology (ASH) - Orlando, FL
Duration: 2010 Dec 42010 Dec 7